Suppression of the natriuretic effects of exogenous atrial natriuretic peptide in animals with total artificial hearts.
Atrial natriuretic peptide (ANP) was administered intravenously to three goats at a dose of 0.1 micrograms/kg/min for 40 min both before total artificial heart (TAH) placement and at 1, 7, and 14 postoperative weeks to determine whether exogenous ANP exhibits the same effect on animals with TAHs as it does on normal animals. No significant changes in the increases in plasma levels of ANP and cyclic guanosine monophosphate (c-GMP) were observed during ANP administration after TAH insertion. In preoperative animals, urine volume and urinary sodium excretion increased greatly during ANP administration, but this natriuretic effect was strongly suppressed in TAH animals. The changes in the decreases in arterial pressure and in central venous pressure (CVP) or right atrial pressure that occurred during the administration of ANP were not significant either pre- or post-operatively. Thus, only the natriuretic effect of ANP on the kidney was significantly suppressed in TAH animals, which might be due to some down-regulation of ANP receptors in the kidney, the production of some antagonists of ANP, sympathetic hypertonicity, or the elevation of CVP.
Mabuchi
K
K
Research Center for Advanced Science and Technology, University of Tokyo, Japan.
Hayakawa
H
H
Hirata
Y
Y
Iizuka
M
M
Imachi
K
K
Chinzei
T
T
Nozawa
H
H
Abe
Y
Y
Yonezawa
T
T
Suzukawa
M
M
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D006152:Cyclic GMP / Q000097:blood; D006041:Goats; D006354:Heart, Artificial; D007262:Infusions, Intravenous; D009318:Natriuresis / Q000187:drug effects*
D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP